Literature DB >> 2257298

Highly increased production of bone marrow-derived blood cells by administration of homologous interleukin-3 to rhesus monkeys.

G Wagemaker1, F C van Gils, H Burger, L C Dorssers, R W van Leen, N L Persoon, J J Wielenga, J L Heeney, E Knol.   

Abstract

Recombinant rhesus monkey interleukin-3 (IL-3) was administered to normal rhesus monkeys in graded doses ranging from 3 to 30 micrograms/kg/d subcutaneously for 30 consecutive days or given as a continuous intravenous infusion at a dose of 30 micrograms/kg/d for 16 days. After a lag phase of about 1 week, a highly increased, dose-dependent production of bone marrow-derived blood cells was observed, preceded by amplification of bone marrow hematopoietic progenitor cells. Simultaneously, peripheral blood progenitor cells rose. The increase included basophilic, eosinophilic and neutrophilic granulocytes, monocytes, and the erythrocyte and platelet lineages. Characteristically, a T-lymphocyte response was absent. It is concluded that IL-3 in vivo stimulates blood cell production from an immature, multipotent progenitor cell.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257298

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

2.  The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma. A phase-I study.

Authors:  J M Raemaekers; G W van Imhoff; L F Verdonck; J A Hessels; W E Fibbe
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

3.  IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P).

Authors:  F Hladik; K Kolbe; E U Irschick; M J Aman; G Gerken; L Färber; E Liehl; C Peschel; W E Aulitzky; C Huber
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

4.  Molecular evolution of interleukin-3.

Authors:  H Burger; G Wagemaker; J A Leunissen; L C Dorssers
Journal:  J Mol Evol       Date:  1994-09       Impact factor: 2.395

5.  Acute side effects of homologous interleukin-3 in rhesus monkeys.

Authors:  F C van Gils; A H Mulder; C van den Bos; H Burger; R W van Leen; G Wagemaker
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

6.  A human interleukin 3 analog with increased biological and binding activities.

Authors:  A F Lopez; M F Shannon; S Barry; J A Phillips; B Cambareri; M Dottore; P Simmons; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

7.  Scorpion venom peptide SPVII promotes irradiated cells proliferation and increases the expression of the IL-3 receptor.

Authors:  Yifang Qiu; Liyuan Jiang; Caixia Wang; Yan Wang; Ting Li; Baiqian Xing; Meixun Zhou; Tianhan Kong; Weihua Dong
Journal:  Cell Biosci       Date:  2013-07-08       Impact factor: 7.133

8.  Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

Authors:  M W Dercksen; K Hoekman; W W ten Bokkel Huinink; E M Rankin; R Dubbelman; H van Tinteren; J Wagstaff; H M Pinedo
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.